Eye on AI Weekly Research Watch
Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies
· 2 min · Temporada 1
Notas del episodio
Predicting whether breast cancer patients will respond to neoadjuvant therapy is hard because labeled clinical data is scarce. This two-stage model first learns to infer gene expression from histopathology images, trained on 8,742 patients across 32 cancer types, then predicts pathological complete response from inferred expression plus clinical variables. Evaluated on 1,412 patients across nine cohorts, it reaches a pooled AUROC of 0.79, works within molecular subtypes, outperforms histopathological biomarkers, and tolerates minimal biopsy tissue.
Authors: Jungkyu Park, Dhruva Biswas…
Web: share.transistor.fm
